Acorah Software Products - Accounts Production 19.4.300 false true 15 December 2025 16 December 2024 false 16 December 2025 31 December 2025 31 December 2025 16139149 Mr Haider Alhaydari iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 16139149 2025-12-15 16139149 2025-12-31 16139149 2025-12-16 2025-12-31 16139149 frs-core:ShareCapital 2025-12-31 16139149 frs-core:RetainedEarningsAccumulatedLosses 2025-12-31 16139149 frs-bus:PrivateLimitedCompanyLtd 2025-12-16 2025-12-31 16139149 frs-bus:FilletedAccounts 2025-12-16 2025-12-31 16139149 frs-bus:SmallEntities 2025-12-16 2025-12-31 16139149 frs-bus:AuditExempt-NoAccountantsReport 2025-12-16 2025-12-31 16139149 frs-bus:SmallCompaniesRegimeForAccounts 2025-12-16 2025-12-31 16139149 frs-bus:Director1 2025-12-16 2025-12-31 16139149 frs-countries:EnglandWales 2025-12-16 2025-12-31 16139149 2024-12-15 16139149 2025-12-15 16139149 2024-12-16 2025-12-15 16139149 frs-core:ShareCapital 2024-12-15 16139149 frs-core:ShareCapital 2025-12-15 16139149 frs-core:RetainedEarningsAccumulatedLosses 2024-12-16 2025-12-15 16139149 frs-core:RetainedEarningsAccumulatedLosses frs-core:PreviouslyStatedAmount 2024-12-15 16139149 frs-core:RetainedEarningsAccumulatedLosses 2025-12-15
Registered number: 16139149
BORDON PHARMA LTD
Unaudited Financial Statements
For the Period 16 December 2025 to 31 December 2025
Contents
Page
Balance Sheet 1
Statement of Changes in Equity 2
Notes to the Financial Statements 3
Page 1
Balance Sheet
Registered number: 16139149
31 December 2025 15 December 2025
Notes £ £ £ £
CURRENT ASSETS
Cash at bank and in hand 1 1
1 1
Creditors: Amounts Falling Due Within One Year 4 (300 ) (300 )
NET CURRENT ASSETS (LIABILITIES) (299 ) (299 )
TOTAL ASSETS LESS CURRENT LIABILITIES (299 ) (299 )
NET LIABILITIES (299 ) (299 )
CAPITAL AND RESERVES
Called up share capital 5 1 1
Profit and Loss Account (300 ) (300 )
SHAREHOLDERS' FUNDS (299) (299)
For the period ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Haider Alhaydari
Director
10/09/2026
The notes on page 3 form part of these financial statements.
Page 1
Page 2
Statement of Changes in Equity
Share Capital Profit and Loss Account Total
£ £ £
As at 16 December 2024 1 - 1
Loss for the year and total comprehensive income - (300 ) (300)
As at 15 December 2025 and 16 December 2025 1 (300 ) (299)
As at 31 December 2025 1 (300 ) (299)
Page 2
Page 3
Notes to the Financial Statements
1. General Information
BORDON PHARMA LTD is a private company, limited by shares, incorporated in England & Wales, registered number 16139149 . The registered office is 20 PORCHESTER ROAD, KINGSTON UPON THAMES, KT1 3PS.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
3. Average Number of Employees
Average number of employees, including directors, during the period was: NIL (2025: NIL)
- -
4. Creditors: Amounts Falling Due Within One Year
31 December 2025 15 December 2025
£ £
Other creditors 300 300
5. Share Capital
31 December 2025 15 December 2025
£ £
Allotted, Called up and fully paid 1 1
Page 3